David D. Meek, CEO: Mirati Therapeutics MRTX Sell · Filed 23/01/19

Trade details

Type: Insider sale
Amount: $134,726.02
Shares · price: 3,179 sh · $42.38 a share
Held after: 61,792 sh
Stock: Mirati Therapeutics MRTX
Person: David D. MeekCEO
Trade date: 23/01/17
Filed: 23/01/19
Days to filing: 2 days

Sold 4.9% of holdings

Share of holding sold: 4.9%

Mirati Therapeutics trades, last 26 weeks

What else happened in Mirati Therapeutics around then

Filed or reported within 30 days of the trade day · 22/12/18~23/02/16

David D. Meek's recent trades

David D. MeekDirector
SelluniQure
Sell
uniQure
QURE
$53.9K
1,993 sh
$53.9K
Filed 06/12
Traded 06/11
David D. MeekDirector
Planned saleuniQure
Planned sale
uniQure
QURE
$53.9K
1,993 sh
$53.9K
Filed 06/11
Traded 06/11
David D. MeekDirector
SelluniQure
Sell
uniQure
QURE
$30.5K
2,112 sh
$30.5K
Filed 25/06/24
Traded 25/06/20
David D. MeekDirector
SelluniQure
Sell
uniQure
QURE
$11.4K
2,229 sh
$11.4K
Filed 24/06/17
Traded 24/06/13
David D. MeekDirector
SelluniQure
Sell
uniQure
QURE
$43.2K
2,290 sh
$43.2K
Filed 23/06/20
Traded 23/06/16